Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (28370)	2/22/1999 10:25:00 PM
From: Arthur Radley	Read Replies (2) \| Respond to of 32384

This just goes to prove this guy doesn't know what he is talking about....Targretin has not been approved for anything. It was Panretin. Doesn't he know the difference or I'm I wrong again?

To: bob zagorin who wrote (28370)	2/22/1999 10:27:00 PM
From: Machaon	Read Replies (2) \| Respond to of 32384

<< BOP continues solid green but all momentum indicators followed the price down. >> I was wondering what the BOP would say. If you look at the Intraday chart, the volume does not chase the price down. The stock drops first, and then the volume kicks in. The way I figure, which is usually wrong, we need one more movement down, with significant volume kicking in at the low, before we turn back up. Re: CTSL-- Good article except for: ======> "one of which is Targretin, just approved in gel form for Kaposi's sarcoma." It's coming, but it ain't here yet. Regards, Bob